Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Jun 15, 2023; 15(6): 1036-1050
Published online Jun 15, 2023. doi: 10.4251/wjgo.v15.i6.1036
Published online Jun 15, 2023. doi: 10.4251/wjgo.v15.i6.1036
Figure 2 Age-adjusted Charlson comorbidity index-based enhanced regression nomogram to predict the overall survival of perihilar cholangiocarcinoma patients.
ACCI: Age-adjusted Charlson comorbidity index; OS: Overall survival. aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Pan Y, Liu ZP, Dai HS, Chen WY, Luo Y, Wang YZ, Gao SY, Wang ZR, Dong JL, Liu YH, Yin XY, Liu XC, Fan HN, Bai J, Jiang Y, Cheng JJ, Zhang YQ, Chen ZY. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma. World J Gastrointest Oncol 2023; 15(6): 1036-1050
- URL: https://www.wjgnet.com/1948-5204/full/v15/i6/1036.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i6.1036